REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Max 164 S.R.O. (Slovakia)

Main Activities: Wholesale Trade Agents and Brokers
Full name: Dr.Max 164 S.R.O. Profile Updated: October 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dr.Max 164 S.R.O. is an enterprise located in Slovakia, with the main office in Kosice. It operates in the Wholesale Trade Agents and Brokers industry. It was first established on November 29, 2018. The total number of employees is currently 5 - 9 (2023). There was a net sales revenue increase of 37.58% reported in Dr.Max 164 S.R.O.’s latest financial highlights for 2023. During that time, Dr.Max 164 S.R.O.’s total assets grew by 25.35%. The enterprise’s net profit margin decreased by 1.93% in 2023.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 164 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 164 S.R.O. report to view the information.
Outstanding Shares:
Purchase the Dr.Max 164 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 164 S.R.O. report to view the information.
Incorporation Date:
November 29, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 164 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
37.58%
Total operating revenue
36.38%
Operating profit (EBIT)
-40.24%
EBITDA
-34.3%
Net Profit (Loss) for the Period
-44.44%
Total assets
25.35%
Total equity
30.83%
Operating Profit Margin (ROS)
-2.57%
Net Profit Margin
-1.93%
Return on Equity (ROE)
-31.92%
Debt to Equity Ratio
0.52%
Quick Ratio
0.12%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?